LIM Group, an equestrian health firm, agreed to acquire Audevard, a pharmaceutical company, from Ekkio Capital, a private equity firm. Financial terms were not disclosed. "The group is willing to support Audevard in its development ambition and to innovate alongside it in favor of animal health and well-being," LIM Group.